Roth Capital analyst Sean McGowan lowered the firm’s price target on MGP Ingredients (MGPI) to $41 from $45 but keeps a Buy rating on the shares ahead of its Q1 results. The firm warns that the company’s sales will be more adversely impacted than reflected in its previous model, expecting flattish sales in 2026, even though it continues to believe that shares trade at an excessive discount to peers, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MGPI:
- MGP Ingredients Appoints New Independent Directors to Board
- EU proposes 25% counter-tariffs, Bourbon removed from list, Reuters says
- MGP Ingredients director sells $1.67M in common stock
- MGP Ingredients Redesigns Long-Term Incentive Program
- MGP Ingredients price target lowered to $45 from $50 at Roth MKM